Altimmune Appoints M. Scott Harris, M.D. as Chief Medical Officer

NEXT STORY
Kaleido Biosciences to Collaborate with Gustave Roussy Cancer Center to Develop Microbiome Metabolic Therapies (MMT™) in Immuno-oncology
PREV STORY
Fennec Appoints Shubh Goel as Chief Commercial Officer
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Diffusion Pharmaceuticals Appoints Biotech Industry Veteran Isaac Blech to Board of Directors

CHARLOTTESVILLE, Va., Aug. 15, 2016 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (OTCQX:DFFN), a clinical ...

author_avatar
NASDAQ Market News

Five Prime Therapeutics to Present at 36th Annual J.P. Morgan Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Jan. 03, 2018 (GLOBE NEWSWIRE) -- Five Prime Therapeutics, Inc. (Nasdaq:FPRX), ...

author_avatar
NASDAQ Market News

AstraZeneca further sharpens focus through agreement with Genzyme for rare disease medicine Caprelsa

27 July 2015 AstraZeneca today announced that it has entered into a definitive agreement ...

author_avatar
NASDAQ Market News